Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CLDX | C | Celldex Therapeutics, Inc. | 0.43 | |
RCUS | C | Arcus Biosciences, Inc. | 3.68 | |
MRTX | C | Mirati Therapeutics, Inc. | 0.00 | |
LXRX | C | Lexicon Pharmaceuticals, Inc. | 9.59 | |
REGN | C | Regeneron Pharmaceuticals, Inc. | -0.39 | |
NBIX | C | Neurocrine Biosciences, Inc. | 0.07 | |
DCTH | C | Delcath Systems, Inc. | -6.29 | |
XTLB | C | XTL Biopharmaceuticals Ltd. | 4.07 | |
FBIO | C | Fortress Biotech, Inc. | -7.83 | |
LIFE | C | aTyr Pharma, Inc. | -2.50 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | D | PowerShares Dynamic Biotech & Genome | 13.19 | |
BBH | B | Market Vectors Biotech ETF | 10.57 | |
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 9.69 | |
IBB | C | iShares Nasdaq Biotechnology Index Fund | 9.55 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 8.55 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles